Vera Cavalcanti de Araújo

Vera Cavalcanti de Araújo

Auto-generated profile, based on publicly available information

Vera Cavalcanti de Araújo

Faculdade São Leopoldo Mandic, Campinas, Brazil

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
FPFábio Ramôa Pires
Fábio Ramôa Pires
OAOslei Paes de Almeida
Oslei Paes de Almeida
VAVera Cavalcanti de Araújo
Vera Cavalcanti de Araújo
Luiz P. KowalskiLuiz P. Kowalski
Luiz P. Kowalski
Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor, accounting for about 3% to 15% of all salivary gland tumors and 12% to 40% of malignancies.1-5 Histologically, MEC has been classified as low, intermediate, or high grade, according to its cytological features, pattern of invasion, and cellular type.6,7 Several clinical and histological prognostic factors for MEC have been considered, but the most consistent ones are clinical stage and histological grade of the tumor.1-10 Expression of some immunohistochemical markers is also a prognostic factor in patients with MEC10-17; however, few studies10,11,16,17 have considered the effect of clinical, histological, and immunohistochemical variables in a large series of MECs from different sites.

18 May 2005 in Histopathology
Verified
Journal Article
Closed access
PDF file
AAA Altemani
A Altemani
MMM T Martins
M T Martins
LFL Freitas
L Freitas
FSF Soares
F Soares
NAN S Araújo
N S Araújo
VAV C Araújo
V C Araújo

1 January 2013 in Archives of Oral Biology
Verified
Journal Article
Closed access
SCSheila Cavalca Cortelli
Sheila Cavalca Cortelli
JCJosé Roberto Cortelli
José Roberto Cortelli
RRRogério Lima Romeiro
Rogério Lima Romeiro
FCFernando Oliveira Costa
Fernando Oliveira Costa
DADavi Romeiro Aquino
Davi Romeiro Aquino
PDPoliana Mendes Duarte
Poliana Mendes Duarte

1 May 1995 in Oral Oncology
Verified
Journal Article
Closed access
ALA.M. Loyola
A.M. Loyola
VAV.C. de Araújo
V.C. de Araújo
SSS.O.M. de Sousa
S.O.M. de Sousa
NAN.S. de Araújo
N.S. de Araújo

1 September 2020 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
LCLarissa Rocha Bertelli Cabral
Larissa Rocha Bertelli Cabral
LTLucas Novaes Teixeira
Lucas Novaes Teixeira
RGRodrigo Pinto Gimenez
Rodrigo Pinto Gimenez
ADAna Paula Dias Demasi
Ana Paula Dias Demasi
RBRui Barbosa de Brito
Rui Barbosa de Brito
EMElizabeth Ferreira Martinez
Elizabeth Ferreira Martinez
Purpose: Skin ageing is marked by structural and functional changes in epidermis and dermis, which result clinically in wrinkles, loss of elasticity, and rough-textured appearance. In this context, different dermal fillers have been used to overcome these negative effects associated with skin ageing, such as hyaluronic acid (HA) and poly-L-lactic acid (PLLA). Despite their low immunogenicity, these materials can cause an inflammatory reaction after application. Materials and Methods: Considering high demand of HA and PLLA as filler material, this study aimed to evaluate their in vitro and in vivo effects. For the in vitro study, human dermal fibroblast cell cultures were supplemented with HA or PLLA for 24, 48, and 72 h. The following parameters were assayed: 1) cell proliferation, 2) cell viability, and 3) quantification of type I collagen by ELISA. For the in vivo study, HA or PLLA was injected in the dermis of Wistar rats and the tissues were collected after 15, 30, and 60 days for histologic evaluation and for quantification of type I collagen by Western blotting. The quantitative data were statistically analyzed using an ANOVA two-way. The significance level was set at 5%. Results: At 72 h, high cell proliferation was observed for HA compared to control (p< 0.05). Cultures exposed to PLLA exhibited a reduction in both cell proliferation and viability compared to control in all time points (p< 0.05). Type I collagen expression was greater in cultures exposed to HA or PLLA compared to control (p< 0.05). Histologic analysis showed the presence of multinucleated cells only in the PLLA group in all experimental time points. Western blotting analysis revealed high content of type I collagen in HA compared to PLLA (p< 0.05). Conclusion: The present study addresses a potentially unfavorable effect of dermal PLLA filler on the fibroblast phenotype, with possible clinical complications, unlike HA.

1 January 2005 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
CFCristiane Furuse
Cristiane Furuse
SSSuzana O. Machado de Sousa
Suzana O. Machado de Sousa
FNFabio Daumas Nunes
Fabio Daumas Nunes
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
VAVera Cavalcanti de Arauijo
Vera Cavalcanti de Arauijo
We compared the immunoexpression of 5 myoepithelial cell (MEC) markers (asmooth-muscle actin, calponin, h-caldesmon, vimentin, and S-100-protein) using 16 pleomorphic adenomas (PA), 15 adenoid cystic carcinomas (ACC), and 3 epithelialmyoepithelial carcinomas (EMC) of salivary glands. The cx-smooth-muscle actin was useful for identification of MECs, especially in cribriform and tubular ACC, followed by EMC. Calponin was similar to ct-smooth-muscle actin, except for polygonal and plasmacytoid cells of PA and for solid ACC, which showed a-smooth-muscle actin negative and calponin positive. H-caldesmon was negative. Vimentin immunostained all MEC types, and was negative in luminal cells. S-100 protein was expressed both in the nuclei and cytoplasm of MECs and luminal cells, especially in PA. The best way to identify MEC is using a-smooth-muscle actin or calponin, plus vimentin, since in tumors MECs are hardly ever fully differentiated.